Anita Mamtani, MD, FACS
Breast Surgeon
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Assistant Attending Surgeon
I am a breast surgical oncologist with a practice dedicated to the treatment of breast diseases. I perform all types of breast surgery. This includes breast conservation (lumpectomy), mastectomy, and nipple-sparing mastectomy, as well as all types of axillary lymph node procedures.
I work closely with my colleagues in breast imaging, medical oncology, radiation oncology, and plastic surgery to deliver the highest quality of care. I see patients at the Evelyn H. Lauder Breast Center and at MSK Bergen.
Read more
I consider it a great privilege to support my patients throughout their treatment journey. When I meet with them, I aim to provide a clear and comprehensive understanding of their diagnosis and then recommend a care plan that offers the best possible outcome. I want to equip patients with the ability to move forward confidently and comfortably, knowing that my team and I are dedicated to providing compassionate and effective care every step of the way.
In addition to caring for patients, I am involved in research to improve breast cancer care and outcomes. I have done studies on various aspects of surgery of the axilla (armpit) in breast cancer. I have also researched understudied groups of people with breast cancer, including the young and the elderly, as well as those with ductal carcinoma in situ (DCIS) and invasive lobular breast cancer. My work has been presented at national meetings. I maintain active membership in local and national societies, including the American College of Surgeons, the Society of Surgical Oncology, and the American Society of Clinical Oncology.
Outside of work, I enjoy reading, exercising, exploring new cuisines and good eats in New York City, and spending time with my family.
A breast surgeon is a doctor with special training in surgery on breasts.
My Specialties
- Breast Disease
Education
- MD, Jefferson Medical College
Residencies
- General Surgery - Beth Israel Deaconess Medical Center/Harvard Medical School
Awards and Honors
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
- Castle Connolly Top Doctors – Rising Star (2021)
- Chairman’s Award for Excellence in Clinical Research, Memorial Sloan Kettering Cancer Center (2016)
Fellowships
- Breast Surgical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Surgery
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Mamtani sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Selected Publications
Mamtani A, Sevilimedu V, Le T, Morrow M, Barrio AV. Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy? Cancer. 2022 Feb 1;128(3):471-478. doi: 10.1002/cncr.33929. Epub 2021 Oct 1. PMID: 34597420; PMCID: PMC8776569.
Mamtani A, Zabor EC, Stempel M, Morrow M. Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers. Ann Surg Oncol. 2019 Oct;26(10):3269-3274. doi: 10.1245/s10434-019-07536-z. Epub 2019 Jul 24. PMID: 31342363; PMCID: PMC6669889.
Mamtani A, Nakhlis F, Downs-Canner S, Zabor EC, Morrow M, King TA, Van Zee KJ. Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma in Situ. Ann Surg Oncol 2019 (Epub).
Mamtani A, Zabor EC, Rosenberger LH, Stempel M, Gemignani ML, Morrow M. Was Reexcision Less Frequent for Patients with Lobular Breast Cancer After Publication of the SSO-ASTRO Margin Guidelines? Ann Surg Oncol 2019 (Epub).
Mamtani A, King TA. Lobular Breast Cancer: Different Disease, Different Algorithms? Surg Oncol Clin N Am 2018;27(1):81-94.
Mamtani A, Patil S, Stempel MM, Morrow M. Are there patients with T1 to T2, lymph node-negative breast cancer who are “high-risk” for locoregional disease recurrence? Cancer 2017;123(14):2626-33.
Mamtani A, Patil S, Stempel M, Morrow M. Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer. Ann Surg Oncol 2017;24(8):2182-8.
Mamtani A, Barrio AV, King TA, Van Zee KJ, Plitas G, Pilewskie M, El-Tamer M, Gemignani ML, Heerdt AS, Sclafani LM, Sacchini V, Cody HS, 3rd, Patil S, Morrow M. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study. Ann Surg Oncol 2016;23(11):3467-74.
Mamtani A, Gonzalez JJ, Neo D, Slanetz PJ, Houlihan MJ, Herold CI, Recht A, Hacker MR, Sharma R. Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical Outcomes. Ann Surg Oncol 2016;23(10):3371-8.
Mamtani A, Patil S, Van Zee KJ, Cody HS, 3rd, Pilewskie M, Barrio AV, Heerdt AS, Morrow M. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases. Ann Surg Oncol 2016;23(11):3481-6.
Visit PubMed for a full listing of Dr. Mamtani’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Anita Mamtani discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
